Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.
about
Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study GroupThe efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high-dose chemotherapy as consolidation: a non-cisplatin-based induction approach.Treatment of disseminated non-seminomatous testicular cancer: the European experience.Randomized phase III study comparing paclitaxel-bleomycin, etoposide, and cisplatin (BEP) to standard BEP in intermediate-prognosis germ-cell cancer: intergroup study EORTC 30983.Current status and future perspectives in the treatment of advanced testicular cancer.High-dose chemotherapy and stem cell transplantation for advanced testicular cancerRecent advances in management of patients with platinum-refractory testicular germ cell tumors.A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial.Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours - a retrospective long-term follow-up studyBleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours.A review of second-line chemotherapy and prognostic models for disseminated germ cell tumors.Treatment of relapsed/refractory germ cell tumours: an equipoise between conventional and high dose therapy.Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).Current Management of Refractory Germ Cell Tumors and Future Directions.Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.A phase II trial of paclitaxel in refractory germ cell tumors.Prognostic factors in patients progressing after cisplatin-based chemotherapy for malignant non-seminomatous germ cell tumoursSalvage therapy of germ cell tumours.High-dose chemotherapy with peripheral blood stem cell transplantation for advanced testicular cancer.Irinotecan plus cisplatin has substantial antitumor effect as salvage chemotherapy against germ cell tumors.Treatment outcome of patients with brain metastases from malignant germ cell tumors.Complete response to paclitaxel, ifosfamide, and cisplatin therapy in a case of ovarian ependymoma.New prospects for the treatment of germ-cell tumours.
P2860
Q33344289-CE86B351-0F8C-4010-931F-258E0375B5E7Q33418902-02CDDA0F-1E7A-46AF-B45B-9A8E18ED7319Q33788904-02DF5ECC-7DFE-42B9-9209-8084216E0011Q34136937-54D9061A-C196-4ED7-B8E5-50B0B0934A5DQ34612225-2951F863-41ED-4C9C-8420-9A5E96FBC4BAQ35660641-3B4AD4B1-9E6C-468B-8DDC-1158C308FFBFQ36389456-2DC77654-6F47-46C6-A2DB-3E2A9AA53D5FQ36615043-1C775EFA-E481-4120-BE05-C190BF74FC8EQ36671672-68537C4E-30DF-487C-8839-383F935620ABQ36694538-AFEEDF26-8FED-4494-985F-A4D780068A39Q37875412-03BA8FF9-0F42-4F13-882B-E136FBA00B47Q38012658-E0067310-2517-45DD-A3A1-1C4635235026Q38275537-90E05D84-2D8B-40D8-B1EC-494A49AB9503Q38755132-2AD74E3F-6E95-4DB6-9401-90112805C6F6Q38806893-F78D890C-1239-4E34-9545-43B0B5AD588AQ40640064-737B6699-DB86-4C8C-BE1D-7F22186FB748Q42280644-84D881DC-DA29-4F55-BE6E-4B76AEE87A89Q42590636-F9C6A2A2-D5F4-4295-8AA0-D768ADC0B20BQ43993231-0D00C75B-AFCF-44F9-80F2-A52C81361124Q44197097-915BFDEE-4AF4-41D4-9BE8-38E18DE95BEAQ48255023-01B04FB5-6F8C-4811-B62D-AF829375BBC7Q52981291-7CB1C05D-AE4F-458F-92C5-EA2DC394333AQ53852780-E9D4D52B-620F-4C34-8D7F-A025E007B00D
P2860
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Phase II trial of paclitaxel s ...... usly treated germ cell tumors.
@en
type
label
Phase II trial of paclitaxel s ...... usly treated germ cell tumors.
@en
prefLabel
Phase II trial of paclitaxel s ...... usly treated germ cell tumors.
@en
P2093
P1476
Phase II trial of paclitaxel s ...... usly treated germ cell tumors.
@en
P2093
D F Bajorin
H S Hutter
L H Schwartz
R J Motzer
P304
P356
10.1200/JCO.1994.12.11.2277
P407
P577
1994-11-01T00:00:00Z